NCT06882824View on ClinicalTrials.gov

Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 12, 2025

Primary Completion Date

April 17, 2027

Study Completion Date

April 17, 2028

Conditions
Myoma;UterusMyomectomy; Surgical Blood Loss
Interventions
PROCEDURE

myomectomy with placebo

myomectomy after administration of placebo (control group)

PROCEDURE

myomectomy with misoprostol

myomectomiy after administration of misoprostol 400μg PO (experimental group)

Trial Locations (1)

63000

RECRUITING

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER